Loading...

Recent search criteria

Media
- Media
- Press Release
Investors
Careers
- Careers
- Careers
- Working at Ipsen
- Our Culture

Loading...
Australia
< Back
- Global EN FR
- Annual Report EN FR
United States

Brazil

Canada EN

Canada FR

Australia

China

Singapore

South Korea

Belgium

Ukraine

UK

Germany

France

Nordics

Greece

Italy

Netherlands

Spain

Poland

Russia

Slovakia

Czech Republic

Home
Company
- Company
- Company
- Leadership
- History
- Foundation Ipsen
Science
- Science
- Therapeutic Areas
- Products
- R&D
- Pipeline
- Clinical Trials
Responsibility
- Responsibility
- Responsibility
- Environment
- Patients
- People
- Governance
Patients

Home
Stories
Neuroscience story

Testing stories

Back

Post navigation

Testing stories

Test

Testing stories

- 10 January 2024 - 1 mins read

Test

Post navigation

Related Documents

Related links

test

Product/Medical Information

IPN price

€113.00

€0.70 (0.62%)

Media
Investors
Careers

Company
Responsibility
Patients

Annual Report
Contact us
Distribution

Terms and conditions
Cookie Policy
Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2024 Date of preparation: April 2024 CRSC-AU-000016

You are now leaving the Ipsen Australia website. To continue, please click on Continue?